2021年最新SCI期刊影响因子查询系统
BIOORGANIC & MEDICINAL CHEMISTRY 期刊详细信息
基本信息
期刊名称 | BIOORGANIC & MEDICINAL CHEMISTRY BIOORGANIC & MEDICINAL CHEMISTRY |
---|---|
期刊ISSN | 0968-0896 |
期刊官方网站 | http://www.sciencedirect.com/science/journal/09680896 |
是否OA | 否 |
出版商 | Elsevier Ltd |
出版周期 | Semimonthly |
始发年份 | 1993 |
年文章数 | 597 |
最新影响因子 | 3.461(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学3区 | BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学3区 | 否 | 否 |
CHEMISTRY, MEDICINAL 药物化学3区 | |||
CHEMISTRY, ORGANIC 有机化学3区 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 2.85 | 0.747 | 0.877 |
Biochemistry, Genetics and Molecular Biology Clinical Biochemistry |
34 / 115 | 70% |
|||
Pharmacology, Toxicology and Pharmaceutics Pharmaceutical Science |
37 / 164 | 77% |
|||
Chemistry Organic Chemistry |
44 / 177 | 75% |
|||
Pharmacology, Toxicology and Pharmaceutics Drug Discovery |
45 / 146 | 69% |
|||
Biochemistry, Genetics and Molecular Biology Molecular Medicine |
74 / 165 | 55% |
|||
Biochemistry, Genetics and Molecular Biology Biochemistry |
149 / 407 | 63% |
|||
Biochemistry, Genetics and Molecular Biology Molecular Biology |
165 / 375 | 56% |
补充信息
自引率 | 6.20% |
---|---|
H-index | 129 |
SCI收录状况 |
Science Citation Index
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0968-0896%5BISSN%5D |
投稿指南
期刊投稿网址 | http://ees.elsevier.com/bmc/ |
---|---|
收稿范围 | Bioorganic & Medicinal Chemistry publishes complete accounts of research of outstanding significance and timeliness on all aspects of molecular interactions at the interface of chemistry and biology, together with critical review articles. The journal publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. The Journal welcomes papers on: the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targets the reporting of the discovery, design or optimization of potent new compounds or biological agents the analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental data the reporting of "first-in-class" new therapeutic compounds the chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanism methodological advances that are chemistry-based and which significantly impact on medicine or biology the preparation and examination of biotherapeutics for the treatment of pathophysiological disease states the development of materials for specific therapeutic targeting All manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMC is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field. |
收录体裁 | original research Reviews Perspectives Symposia-in-Prin |
投稿指南 | https://www.elsevier.com/journals/bioorganic-and-medicinal-chemistry/0968-0896/guide-for-authors |
投稿模板 | |
参考文献格式 | https://www.elsevier.com/journals/bioorganic-and-medicinal-chemistry/0968-0896/guide-for-authors |
编辑信息 |